Cargando…
Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution
We report a coronavirus disease 2019 case with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persisting beyond 333 days in an immunocompromised patient with chronic lymphocytic leukemia, asymptomatically carrying infectious SARS-CoV-2 at day 197 postdiagnosis. In addition, viral seque...
Autores principales: | Monrad, Ida, Sahlertz, Signe Risgaard, Nielsen, Stine Sofie Frank, Pedersen, Louise Ørnskov, Petersen, Mikkel Steen, Kobel, Carl Mathias, Tarpgaard, Irene Harder, Storgaard, Merete, Mortensen, Klaus Leth, Schleimann, Mariane H, Tolstrup, Martin, Vibholm, Line K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244814/ https://www.ncbi.nlm.nih.gov/pubmed/34258320 http://dx.doi.org/10.1093/ofid/ofab295 |
Ejemplares similares
-
SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity
por: Nielsen, Stine SF, et al.
Publicado: (2021) -
SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses
por: Vibholm, Line K, et al.
Publicado: (2021) -
CD169 (Siglec-1) as a Robust Human Cell Biomarker of Toll-Like Receptor 9 Agonist Immunotherapy
por: Lende, Stine Sofie Frank, et al.
Publicado: (2022) -
Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal study
por: Hvidt, Astrid Korning, et al.
Publicado: (2023) -
Redirector of Vaccine-induced Effector Responses (RoVER) for specific killing of cellular targets
por: Konrad, Christina V., et al.
Publicado: (2023)